| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 708446 | Null | 0.0181211508101519 | 0.14175118 |
| NSC 717708 | Null | 0.0181211508101519 | -0.031829779 |
| NSC 721951 | S-dimethylarsinogluthaione, pyridinium hydrochloride | 0.0181211508101519 | 0.34033685 |
| NSC 732822 | N1-(3-trifluoromethylphenyl)-3-(1-benzyl-4-chloro-2,5-dioxo- 2,5-dihydro-1H-3-pyrrolylamino)benzamide | 0.0181211508101519 | 0.49289156 |
| NSC 735333 | Null | 0.0181211508101519 | 0.28185868 |
| NSC 742256 | 8-(4-Amino-1-methylbutyl)amino-2-methyl-5,6-dihydroxyquinoline, 2.3-hydrobromide, 0.8 hydrate | 0.0181211508101519 | 0.3487458 |
| NSC 92915 | ANTINEOPLASTIC-92915 | 0.0181211508101519 | 0.64881214 |
| NSC 9598 | 3-(Dimethylamino)-7-(methylimino)-3H-phenothiazine hydrochloride | 0.0181211508101519 | 0.38197811 |
| NSC 668257 | 2,4(1H,3H)-Pyrimidinedione, 1-[[2-(4-chlorophenyl)- tetrahydro-4-methylene-5-oxo-2-furanyl]methyl]-5-methyl- | 0.0187206825450445 | 0.55747719 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0208632511155816 | 0.4880571 |